|
Re: Breakout
|
1
|
Mannkind
|
Mar 11, 2013 05:51PM
|
|
Re: Insulin pill
|
1
|
Mannkind
|
May 24, 2012 12:21PM
|
|
Re: Cowen and Company
|
1
|
Mannkind
|
Feb 20, 2013 06:20PM
|
|
Re: Adam Feuerstein's latest hit piece!
|
1
|
Mannkind
|
Aug 23, 2013 09:26AM
|
|
Re: Jan 2015 options released...
|
1
|
Mannkind
|
Oct 15, 2012 02:22PM
|
|
Re: Q2'12 CC Notes & Thoughts
|
1
|
Mannkind
|
Aug 07, 2012 07:44PM
|
|
Re: Drugmaker Eli Lilly to cut 1,000 U.S. sales jobs
|
1
|
Mannkind
|
Apr 12, 2013 03:17PM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
|
1
|
Mannkind
|
Mar 18, 2013 05:28AM
|
|
Re: Option question....
|
1
|
Mannkind
|
May 17, 2012 07:37PM
|
|
Re: MNKD Presents at ADA conference
|
1
|
Mannkind
|
Jun 09, 2013 09:55PM
|
|
Re: Updated Share Price Model
|
1
|
Mannkind
|
Jan 18, 2013 07:34PM
|
|
Re: Our competion?
|
1
|
Mannkind
|
Aug 18, 2012 09:52PM
|
|
Bloomberg Businessweek
|
1
|
Mannkind
|
Aug 14, 2013 06:22PM
|
|
Re: BMY just listed hundreds of new diabetes sales positions
|
1
|
Mannkind
|
Aug 07, 2013 07:08PM
|
|
Totally OT
|
1
|
Mannkind
|
Aug 15, 2013 06:05PM
|
|
Griffin Securities - August 2013
|
1
|
Mannkind
|
Aug 26, 2013 08:51AM
|
|
Re: A Future of Doubt: For Diabetes Sufferers, History Forces us to Question the Fut
|
1
|
Mannkind
|
Jun 04, 2012 05:09PM
|
|
Re: MannKind’s Afrezza Likely to Fail AFFINITY 1 Phase III Trial
|
1
|
Mannkind
|
Apr 11, 2013 12:26PM
|
|
Re: Technical view of Mannkind
|
1
|
Mannkind
|
Aug 01, 2013 09:56AM
|
|
Re: Our competion?
|
1
|
Mannkind
|
Jul 23, 2012 12:32PM
|
